Cardiac Support System for Health Failure Patients

Syntach AB is pioneering a revolutionary cardiac support device designed to address the needs of patients suffering from severe heart failure. Their flagship product, the Syntach Cardiac Support (CS) device, represents a significant advancement in minimally invasive cardiac repair technology. This innovative device is engineered to restore the impaired movement of the atrioventricular plane, which is crucial for effective heart function. By utilizing transcatheter techniques, the Syntach CS device can be implanted with reduced risk and improved patient outcomes, making it a promising alternative to traditional left ventricular assist devices (LVADs). 

The Syntach CS device is characterized by its small size, making it suitable for a diverse patient demographic, and it features integrated patient monitoring capabilities. This fully implantable device also incorporates wireless recharging technology, enhancing its usability and patient comfort. Currently, Syntach's products are still under development and have not yet received clinical approval, but the company has garnered attention in the medical community, including recognition at the CRT 2023 annual meeting for its innovative approach to cardiac support.

Sweden

Syntach AB is innovation-driven company based in Lund, Sweden. The Company develops an entirely new class of minimally invasive cardiac support devices and other products aimed and improving the lives of millions of patients living with advanced stage heart failure.

Postal address: Box 4004, SE-227 21 Lund, Sweden. Visiting address: Traktorvägen 6C, SE-226 60 Lund, Sweden, Lund, SE

Syntach AB

Company Details